CEO and founder Wayne Paterson discussed the company’s DurAVR transcatheter aortic valve replacement (TAVR) program, recent ...
LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP) device with significant protection from stroke in patients undergoing ...
Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.
TAVR, a minimally invasive alternative to open‑heart surgery for severe aortic stenosis, has become the global standard for elderly and high‑risk patients.
Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...
The heart team at University Hospitals, Cleveland, OH, was in the midst of implanting a transcatheter aortic valve in an elderly patient when things went abruptly wrong. “The pacemaker happened to ...
SAN ANTONIO, TX—More and more patients who undergo TAVI go on to have cardiac surgery, with high operative mortality, new data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery ...
LONDON -- It was best that people interrupt their oral anticoagulation (OAC) therapy around the time they get transcatheter aortic valve replacement (TAVR, also TAVI), the POPular PAUSE TAVI trial ...
Indian-made Myval and Myval Octacor were put to the test against Sapien 3 in the noninferiority trial COMPARE TAVI-1. Noninferiority was demonstrated when counting deaths, strokes, moderate or severe ...
TAVR is a breakthrough, minimally invasive procedure used to treat severe aortic stenosis, a condition where the aortic valve narrows, hindering blood flow ...
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...